Interleukin-12 induces a Th1-like response to Burkholderia mallei and limited protection in BALB/c mice

被引:32
作者
Amemiya, K [1 ]
Meyers, JL [1 ]
Trevino, SR [1 ]
Chanh, TC [1 ]
Norris, SL [1 ]
Waag, DM [1 ]
机构
[1] USA, Res Inst Infect Dis, Bacteriol Div, Ft Detrick, MD 21702 USA
关键词
IL-12; Th1; response; limited protection;
D O I
10.1016/j.vaccine.2005.09.021
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We evaluated the effect of interleukin (IL)-12 on the immune response to Burkholderia mallei in BALB/c mice. Mice were vaccinated with non-viable B. mallei cells with or without IL-12. There was a seven- to nine-fold increase in IgG2a levels, and a significant increase in the proliferative response and interferon (IFN)-gamma production by splenocytes from mice that received B. mallei and IL-12. We saw an increase in survivors in the groups of mice that received B. mallei and IL-12 when challenged, compared to mice that received only B. mallei or IL-12. The results Suggest that IL-12 can enhance the Th1-like immune response to B. mallei and mediate limited protection from a lethal challenge. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1413 / 1420
页数:8
相关论文
共 41 条
[1]   THE ADJUVANT EFFECT OF INTERLEUKIN-12 IN A VACCINE AGAINST LEISHMANIA-MAJOR [J].
AFONSO, LCC ;
SCHARTON, TM ;
VIEIRA, LQ ;
WYSOCKA, M ;
TRINCHIERI, G ;
SCOTT, P .
SCIENCE, 1994, 263 (5144) :235-237
[2]   Nonviable Burkholderia mallei induces a mixed Th1-and Th2-like cytokine response in BALB/c mice [J].
Amemiya, K ;
Bush, GV ;
DeShazer, D ;
Waag, DM .
INFECTION AND IMMUNITY, 2002, 70 (05) :2319-2325
[3]   Effect of anti-interleukin 12 treatment on murine lyme borreliosis [J].
Anguita, J ;
Persing, DH ;
Rincon, M ;
Barthold, SW ;
Fikrig, E .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (04) :1028-1034
[4]  
[Anonymous], [No title captured]
[5]  
Bohn E, 1996, J IMMUNOL, V156, P1458
[6]  
Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P532
[7]  
Constantinescu CS, 1998, EUR J IMMUNOL, V28, P2227, DOI 10.1002/(SICI)1521-4141(199807)28:07<2227::AID-IMMU2227>3.0.CO
[8]  
2-N
[9]  
COOPER AM, 1995, IMMUNOLOGY, V84, P423
[10]  
Domma K., 1953, WIENER TIERARZTLICHE, V40, P426